FDA.reportPublic FDA data

ertugliflozin 5 MG / SITagliptin 100 MG Oral Tablet

RxCUI
1992835
RxNorm name
ertugliflozin 5 MG / SITagliptin 100 MG Oral Tablet
Display name
ertugliflozin 5 MG / SITagliptin 100 MG Oral Tablet
Full name
ertugliflozin 5 MG / SITagliptin 100 MG Oral Tablet
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:19

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
STEGLUJANERTUGLIFLOZIN AND SITAGLIPTINMerck Sharp & Dohme LLCc2c553d8-5a9d-4366-bf53-8bdb5a876d192026-06-03Warnings, Adverse reactionsExact identifier
rxcui: 1992835

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
c2c553d8-5a9d-4366-bf53-8bdb5a876d19ertugliflozin 5 MG / SITagliptin 100 MG Oral Tablet [PSN] · ertugliflozin 5 MG / sitagliptin 100 MG Oral Tablet [SCD]223These highlights do not include all the information needed to use STEGLUJAN safely and effectively. See full prescribing information for STEGLUJAN. STEGLUJAN ® (ertugliflozin and sitagliptin) tablets, for oral use Initial U.S. Approval: 201720241220